Utilizing machine learning for predicting heart failure outcomes: A path toward developing a patient-centered approach

IF 2.4 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Clinical Cardiology Pub Date : 2024-03-25 DOI:10.1002/clc.24260
Rayyan Nabi MBBS, Tabeer Zahid MBBS, Hanzala A. Farooqi MBBS
{"title":"Utilizing machine learning for predicting heart failure outcomes: A path toward developing a patient-centered approach","authors":"Rayyan Nabi MBBS,&nbsp;Tabeer Zahid MBBS,&nbsp;Hanzala A. Farooqi MBBS","doi":"10.1002/clc.24260","DOIUrl":null,"url":null,"abstract":"<p>Heart failure (HF)—a global pandemic—poses a huge burden to healthcare systems, with a staggering 64.3 million people worldwide estimated to suffer from the ailment in 2017. Projections suggest a total cost of around $69.8 billion for HF by the year 2030 in the United States.<span><sup>1</sup></span> This highlights the immense economic burden of the disease and calls for effective strategies vis-à-vis its treatment and more importantly, prevention. Recent studies have outlined how machine learning (ML) can be used to build predictive models from multidimensional datasets. This has led to the establishment of the role of AI in early detection of future mortality and destabilizing episodes, therefore allowing for the optimization of cardiovascular disease outcomes.<span><sup>2</sup></span></p><p>A recent study published by Ketabi et al. analyzed the performance of 10 ML algorithms and chose the best algorithm to predict mortality and readmission of HF patients.<span><sup>3</sup></span> Two thousand four hundred and eighty-eight patients' information was documented after their first hospital admission and they were then followed to determine three outcomes: hospital readmission, 1-month mortality, and 1-year mortality. 14.7% of these patients were readmitted to the hospital, 3.9% died within a month and 13.7% died within a year. To determine this, 57 different factors were considered independent variables to predict outcomes and were entered into and evaluated using ML algorithms. The data were divided into two sets: training sets for the machine algorithm to teach itself, and test sets for evaluating the classifier's prediction error rate after learning. The five metrics utilized to compare the models were accuracy, sensitivity, specificity, F1 score, and AUC. Out of the 10 ML algorithms, CatBoost (CAT) had the best performance in terms of predicting heart failure outcomes. It identified length of stay in the hospital, haemoglobin level, and family history of MI as the most important predictors for readmission, 1-month mortality, and 1-year mortality, respectively. These findings can thus be significant in helping doctors individualize HF patients at high risk of readmission or death.</p><p>We can therefore conclude that early detection of patients at risk of HF—through the use of ML—will allow for timely interventions to be made. Intensive monitoring of patients predicted to experience a negative outcome will help ensure the development of a more patient-centered approach, forcing clinicians to ensure such patients are of utmost priority and tailor their treatment plans with caution and vigilance. The COACH trial found that using a tool in the emergency department to guide management plans for HF patients, combined with providing standardized transitional care, improved outcomes for such patients.<span><sup>4</sup></span> This supports the idea that a ML-based predictive model will aid in risk-based decision-making leading to better HF patient results, and also help reduce unnecessary hospital readmissions by identifying patients who require more attention post-discharge. Additionally, doctors will be compelled to thoroughly counsel their patients, briefing them regarding specific lifestyle modifications required to lower the already very high risk of experiencing a similar cardiac event in the near future. Moreover, given the immense economic burden HF presents with, the use of ML will allow resources to be allocated efficiently based on predicted risk. In spite of all these merits, the current study has certain limitations including its retrospective design that used the records from the Fasa Registry on Systolic Heart Failure (FaRSH). For this reason, we recommend conducting prospective studies to overcome potential selection bias that may be associated with the study's current design. Moreover, the study population comprised mainly of patients of Arab and Persian ethnicity. Given the differences in incidence of congestive heart failure by ethnicity,<span><sup>5</sup></span> this highlights the need for similar studies to be conducted on a wider geographical scale for more conclusive findings.</p><p>Rayyan Nabi came up with the idea for the letter and drafted the manuscript. Tabeer Zahid helped in writing the manuscript and provided supportive ideas for its completion. Hanzala Ahmed Farooqi reviewed and supervised the article to ensure its clarity.</p><p>The authors declare no conflict of interest.</p>","PeriodicalId":10201,"journal":{"name":"Clinical Cardiology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.24260","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.24260","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Heart failure (HF)—a global pandemic—poses a huge burden to healthcare systems, with a staggering 64.3 million people worldwide estimated to suffer from the ailment in 2017. Projections suggest a total cost of around $69.8 billion for HF by the year 2030 in the United States.1 This highlights the immense economic burden of the disease and calls for effective strategies vis-à-vis its treatment and more importantly, prevention. Recent studies have outlined how machine learning (ML) can be used to build predictive models from multidimensional datasets. This has led to the establishment of the role of AI in early detection of future mortality and destabilizing episodes, therefore allowing for the optimization of cardiovascular disease outcomes.2

A recent study published by Ketabi et al. analyzed the performance of 10 ML algorithms and chose the best algorithm to predict mortality and readmission of HF patients.3 Two thousand four hundred and eighty-eight patients' information was documented after their first hospital admission and they were then followed to determine three outcomes: hospital readmission, 1-month mortality, and 1-year mortality. 14.7% of these patients were readmitted to the hospital, 3.9% died within a month and 13.7% died within a year. To determine this, 57 different factors were considered independent variables to predict outcomes and were entered into and evaluated using ML algorithms. The data were divided into two sets: training sets for the machine algorithm to teach itself, and test sets for evaluating the classifier's prediction error rate after learning. The five metrics utilized to compare the models were accuracy, sensitivity, specificity, F1 score, and AUC. Out of the 10 ML algorithms, CatBoost (CAT) had the best performance in terms of predicting heart failure outcomes. It identified length of stay in the hospital, haemoglobin level, and family history of MI as the most important predictors for readmission, 1-month mortality, and 1-year mortality, respectively. These findings can thus be significant in helping doctors individualize HF patients at high risk of readmission or death.

We can therefore conclude that early detection of patients at risk of HF—through the use of ML—will allow for timely interventions to be made. Intensive monitoring of patients predicted to experience a negative outcome will help ensure the development of a more patient-centered approach, forcing clinicians to ensure such patients are of utmost priority and tailor their treatment plans with caution and vigilance. The COACH trial found that using a tool in the emergency department to guide management plans for HF patients, combined with providing standardized transitional care, improved outcomes for such patients.4 This supports the idea that a ML-based predictive model will aid in risk-based decision-making leading to better HF patient results, and also help reduce unnecessary hospital readmissions by identifying patients who require more attention post-discharge. Additionally, doctors will be compelled to thoroughly counsel their patients, briefing them regarding specific lifestyle modifications required to lower the already very high risk of experiencing a similar cardiac event in the near future. Moreover, given the immense economic burden HF presents with, the use of ML will allow resources to be allocated efficiently based on predicted risk. In spite of all these merits, the current study has certain limitations including its retrospective design that used the records from the Fasa Registry on Systolic Heart Failure (FaRSH). For this reason, we recommend conducting prospective studies to overcome potential selection bias that may be associated with the study's current design. Moreover, the study population comprised mainly of patients of Arab and Persian ethnicity. Given the differences in incidence of congestive heart failure by ethnicity,5 this highlights the need for similar studies to be conducted on a wider geographical scale for more conclusive findings.

Rayyan Nabi came up with the idea for the letter and drafted the manuscript. Tabeer Zahid helped in writing the manuscript and provided supportive ideas for its completion. Hanzala Ahmed Farooqi reviewed and supervised the article to ensure its clarity.

The authors declare no conflict of interest.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用机器学习预测心衰预后:开发以患者为中心的方法之路。
心力衰竭(HF)是一种全球性流行病,给医疗保健系统带来了巨大负担,据估计,2017 年全球有 6430 万人罹患此病。预测显示,到 2030 年,美国因心房颤动造成的总成本约为 698 亿美元。1 这凸显了该疾病造成的巨大经济负担,并呼吁制定有效的治疗策略,更重要的是,制定有效的预防策略。最近的研究概述了如何利用机器学习(ML)从多维数据集中建立预测模型。Ketabi 等人最近发表的一项研究分析了 10 种 ML 算法的性能,并选出了预测高血压患者死亡率和再入院率的最佳算法。3 2,488 名患者在首次入院后被记录了信息,然后对他们进行跟踪,以确定三种结果:再入院率、1 个月死亡率和 1 年死亡率。其中 14.7% 的患者再次入院,3.9% 的患者在一个月内死亡,13.7% 的患者在一年内死亡。为了确定这一点,57 个不同的因素被认为是预测结果的自变量,并被输入到 ML 算法中进行评估。数据分为两组:用于机器算法自学的训练集和用于评估分类器学习后预测错误率的测试集。用于比较模型的五个指标是准确度、灵敏度、特异性、F1 分数和 AUC。在 10 种 ML 算法中,CatBoost(CAT)在预测心衰结果方面表现最佳。它将住院时间、血红蛋白水平和心肌梗死家族史分别确定为再入院、1 个月死亡率和 1 年死亡率的最重要预测因素。因此,我们可以得出这样的结论:通过使用 ML,及早发现有高危风险的高血压患者,以便及时采取干预措施。对预计会出现不良预后的患者进行强化监测将有助于确保制定一种更加以患者为中心的方法,迫使临床医生确保将这类患者作为重中之重,并谨慎而警惕地制定治疗计划。COACH 试验发现,在急诊科使用一种工具来指导高血压患者的管理计划,同时提供标准化的过渡护理,可以改善这类患者的预后。4 这支持了一种观点,即基于 ML 的预测模型将有助于基于风险的决策,从而改善高血压患者的预后,并通过识别出出院后需要更多关注的患者,帮助减少不必要的再入院。此外,医生将不得不为患者提供全面的咨询,向他们介绍需要调整的具体生活方式,以降低在不久的将来发生类似心脏事件的极高风险。此外,考虑到高血压带来的巨大经济负担,使用 ML 可以根据预测风险有效分配资源。尽管有这些优点,但目前的研究仍有一定的局限性,其中包括其回顾性设计,即使用了法萨收缩性心力衰竭登记处(Fasa Registry on Systolic Heart Failure,FaRSH)的记录。因此,我们建议进行前瞻性研究,以克服当前研究设计可能带来的选择偏差。此外,研究人群主要由阿拉伯和波斯裔患者组成。鉴于不同种族充血性心力衰竭的发病率存在差异5 ,这就凸显出有必要在更广泛的地域范围内开展类似研究,以获得更确凿的结论。塔比尔-扎希德(Tabeer Zahid)协助撰写了手稿,并为手稿的完成提供了支持性意见。汉扎拉-艾哈迈德-法鲁奇(Hanzala Ahmed Farooqi)对文章进行了审阅和监督,以确保其清晰明了。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Cardiology
Clinical Cardiology 医学-心血管系统
CiteScore
5.10
自引率
3.70%
发文量
189
审稿时长
4-8 weeks
期刊介绍: Clinical Cardiology provides a fully Gold Open Access forum for the publication of original clinical research, as well as brief reviews of diagnostic and therapeutic issues in cardiovascular medicine and cardiovascular surgery. The journal includes Clinical Investigations, Reviews, free standing editorials and commentaries, and bonus online-only content. The journal also publishes supplements, Expert Panel Discussions, sponsored clinical Reviews, Trial Designs, and Quality and Outcomes.
期刊最新文献
Associations Between Cardiovascular Health (Life's Essential 8) and Mental Disorders A Predictive Nomogram of In-Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit Is There a Need for Sex-Tailored Lipoprotein(a) Cut-Off Values for Coronary Artery Disease Risk Stratification? Anticoagulant Impact on Clinical Outcomes of Pulmonary Embolism Compared With Thrombolytic Therapy; Meta-Analysis Bridging With Low-Molecular-Weight Heparin Versus Antiplatelet Therapy in Patients Undergoing Noncardiac Surgery After Percutaneous Coronary Intervention: A Comprehensive Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1